Nanochitosan antimicrobial activity against Streptococcus mutans and Candida albicans dual-species biofilms

Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early...

Full description

Saved in:
Bibliographic Details
Published inBMC Research Notes Vol. 12; no. 1; pp. 383 - 7
Main Authors Ikono, Radyum, Vibriani, Agnia, Wibowo, Indra, Saputro, Kurniawan Eko, Muliawan, Wibias, Bachtiar, Boy Muchlis, Mardliyati, Etik, Bachtiar, Endang Winiati, Rochman, Nurul Taufiqu, Kagami, Hideaki, Xianqi, Li, Nagamura-Inoue, Tokiko, Tojo, Arinobu
Format Journal Article
LanguageEnglish
Published England Springer Science and Business Media LLC 08.07.2019
BioMed Central Ltd
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability. The present study successfully synthesized nanochitosan with average diameter of approximately 20-30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation.
AbstractList Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability.OBJECTIVEChitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability.The present study successfully synthesized nanochitosan with average diameter of approximately 20-30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation.RESULTSThe present study successfully synthesized nanochitosan with average diameter of approximately 20-30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation.
Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability. The present study successfully synthesized nanochitosan with average diameter of approximately 20-30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation.
Abstract Objective Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability. Results The present study successfully synthesized nanochitosan with average diameter of approximately 20–30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation.
Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability. The present study successfully synthesized nanochitosan with average diameter of approximately 20-30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation.
Objective Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability. Results The present study successfully synthesized nanochitosan with average diameter of approximately 20-30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation. Keywords: Biofilm, Candida albicans, Caries, Nanochitosan, Streptococcus mutans
ArticleNumber 383
Audience Academic
Author Arinobu Tojo
Boy M. Bachtiar
Agnia Vibriani
Kurniawan Eko Saputro
Li Xianqi
Wibias Muliawan
Nurul Taufiqu Rochman
Endang Winiati Bachtiar
Radyum Ikono
Indra Wibowo
Etik Mardliyati
Tokiko Nagamura-Inoue
Hideaki Kagami
Author_xml – sequence: 1
  givenname: Radyum
  orcidid: 0000-0001-9368-8737
  surname: Ikono
  fullname: Ikono, Radyum
– sequence: 2
  givenname: Agnia
  surname: Vibriani
  fullname: Vibriani, Agnia
– sequence: 3
  givenname: Indra
  surname: Wibowo
  fullname: Wibowo, Indra
– sequence: 4
  givenname: Kurniawan Eko
  surname: Saputro
  fullname: Saputro, Kurniawan Eko
– sequence: 5
  givenname: Wibias
  surname: Muliawan
  fullname: Muliawan, Wibias
– sequence: 6
  givenname: Boy Muchlis
  surname: Bachtiar
  fullname: Bachtiar, Boy Muchlis
– sequence: 7
  givenname: Etik
  surname: Mardliyati
  fullname: Mardliyati, Etik
– sequence: 8
  givenname: Endang Winiati
  surname: Bachtiar
  fullname: Bachtiar, Endang Winiati
– sequence: 9
  givenname: Nurul Taufiqu
  surname: Rochman
  fullname: Rochman, Nurul Taufiqu
– sequence: 10
  givenname: Hideaki
  surname: Kagami
  fullname: Kagami, Hideaki
– sequence: 11
  givenname: Li
  surname: Xianqi
  fullname: Xianqi, Li
– sequence: 12
  givenname: Tokiko
  surname: Nagamura-Inoue
  fullname: Nagamura-Inoue, Tokiko
– sequence: 13
  givenname: Arinobu
  surname: Tojo
  fullname: Tojo, Arinobu
BackLink https://cir.nii.ac.jp/crid/1870583643265714304$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/31287001$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1TAQhSNURB_wA9igSLCARYrHThxng1RVPK5U0QWPrTVxJrcuufYldqrbf49DWtSLEIrkWM53TmbG5zg7cN5Rlj0Hdgqg5NsAAlhZMGiKsuS82D3KjqCuZMEqxg4e7A-z4xCuGZOgFDzJDgVwVTMGR9mPz-i8ubLRB3Q5umg31oy-tTjkaKK9sfE2xzVaF2L-JY60jd54Y6aQb6aILiRNl5-nxXaY49BaMx92Ew5F2JKxFPLW-t4Om_A0e9zjEOjZ3fsk-_bh_dfzT8XF5cfV-dlFYaSEWFANzNRN2VDDpTDUp7IZcW4q4mVTK-p7YC1voSaQHAUnTooqoaDFtmJSnGSrxbfzeK23o93geKs9Wv37wI9rjWO0ZiCtoK9lo0j2qErZSJXGCJz10HM0RjTJ693itZ3aDXWGXBxx2DPd_-LslV77G51aEVzWyeD1ncHof04Uot7YYGgY0JGfgua8KitQ6T4T-nJB15hKs673ydHMuD6rGt7wUtSQqNN_UOnpKF1dCkiaNe0L3uwJEhNpF9c4haBXl9_32RcP2_3T531gElAvQApJCCP12tiI0fq5eztoYHqOpl6iqVM09RxNvUtK-Et5b_4_zatF46xNP5pXSHVUSsgyTbeqoRSsFL8AVO_vfQ
CitedBy_id crossref_primary_10_4103_jispcd_JISPCD_163_21
crossref_primary_10_3389_fdmed_2022_849274
crossref_primary_10_3390_pharmaceutics15092253
crossref_primary_10_3390_nano13192649
crossref_primary_10_3390_pharmaceutics15030762
crossref_primary_10_1016_j_mam_2024_101290
crossref_primary_10_1590_pboci_2021_069
crossref_primary_10_1039_D0CC05880G
crossref_primary_10_1590_1678_7757_2021_0120
crossref_primary_10_3389_fchem_2021_813973
crossref_primary_10_1111_1758_2229_13053
crossref_primary_10_3390_pharmaceutics13060803
crossref_primary_10_1016_j_biteb_2022_101218
crossref_primary_10_3389_fphar_2021_760768
crossref_primary_10_1016_j_jmbbm_2023_106134
crossref_primary_10_1016_j_ijbiomac_2021_08_046
crossref_primary_10_1186_s12951_020_00714_2
crossref_primary_10_2174_1874210602014010731
crossref_primary_10_1080_1040841X_2021_1921696
crossref_primary_10_51847_HzJjQ1bn1I
crossref_primary_10_2217_fmb_2023_0259
crossref_primary_10_2147_IJN_S468848
crossref_primary_10_1007_s40242_024_4135_0
crossref_primary_10_3390_molecules26206315
crossref_primary_10_3390_pr8091173
crossref_primary_10_3390_prosthesis6060103
crossref_primary_10_1016_j_jdent_2024_105134
crossref_primary_10_3389_fmicb_2020_538602
crossref_primary_10_1016_j_archoralbio_2020_104822
crossref_primary_10_3390_polym14020230
crossref_primary_10_1016_j_ijbiomac_2024_138324
crossref_primary_10_3390_ph14080752
crossref_primary_10_3390_molecules26071870
crossref_primary_10_1177_22808000211065259
crossref_primary_10_23887_ijnse_v7i1_53897
crossref_primary_10_3389_fcimb_2022_836379
crossref_primary_10_1016_j_optlastec_2022_108930
crossref_primary_10_3390_polym14050908
crossref_primary_10_1039_D0NH00696C
crossref_primary_10_1155_2021_8975948
crossref_primary_10_1590_1678_7757_2023_0146
crossref_primary_10_3389_fmicb_2022_911623
crossref_primary_10_1016_j_sdentj_2021_06_003
crossref_primary_10_3390_microorganisms9020412
crossref_primary_10_3390_polym13193430
crossref_primary_10_5005_jp_journals_10015_2212
crossref_primary_10_12688_f1000research_20700_1
crossref_primary_10_1088_2057_1976_ac0609
crossref_primary_10_12688_f1000research_20700_2
crossref_primary_10_1016_j_jallcom_2020_155366
crossref_primary_10_3390_antibiotics11050623
crossref_primary_10_3389_fcimb_2023_1106231
Cites_doi 10.1111/idj.12261
10.1016/j.addr.2009.09.004
10.1016/j.archoralbio.2008.02.015
10.1128/IAI.00087-14
10.1016/j.addr.2013.07.011
10.1038/ismej.2014.73
10.1016/j.ultramic.2009.03.015
10.3390/pathogens3040908
10.1088/2057-1976/aac9f8
10.1038/srep41332
10.1128/AEM.05203-11
10.1111/j.1751-7915.2008.00080.x
10.1016/j.anaerobe.2012.04.009
10.1155/2016/1851242
10.1128/AEM.02941-10
10.1371/journal.pone.0150457
10.1155/2015/246012
10.1002/macp.1984.021850503
10.1016/j.marenvres.2009.07.001
10.1021/cr030441b
10.3389/fmicb.2016.00140
10.1016/j.fm.2008.05.003
10.1016/j.ijfoodmicro.2010.09.012
10.1016/b978-0-12-800268-1.00002-0
10.3390/nu6093572
10.3390/md8082252
10.1111/j.1532-849X.2012.00906.x
10.1016/j.biomaterials.2008.07.034
10.1016/B978-0-12-800269-8.00012-9
10.1016/j.yrtph.2009.09.015
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
The Author(s) 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: The Author(s) 2019
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
7X8
5PM
DOA
DOI 10.1186/s13104-019-4422-x
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale in Context: Opposing Viewpoints
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1756-0500
EndPage 7
ExternalDocumentID oai_doaj_org_article_81f7698e6fa846968422120f1f2acc39
PMC6613267
A592924371
31287001
10_1186_s13104_019_4422_x
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GrantInformation_xml – fundername: Japan Society for the Promotion of Science
  grantid: ID no: R11525
– fundername: Grant-in-Aid for Scientific Research, JSPS Kakenhi
  grantid: JP16H05546
– fundername: ;
  grantid: JP16H05546
– fundername: ;
  grantid: ID no: R11525
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
INH
INR
IOV
ITC
KQ8
LK8
M1P
M48
M7P
MK0
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
RYH
SBL
SOJ
SV3
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PJZUB
PPXIY
PQGLB
5PM
PUEGO
ID FETCH-LOGICAL-c661t-e710c7949e9263cef0610e22c5e24978eff10b2b17e162a32e2e8e5381bab5063
IEDL.DBID M48
ISSN 1756-0500
IngestDate Wed Aug 27 01:26:07 EDT 2025
Thu Aug 21 14:10:41 EDT 2025
Mon Jul 21 09:21:51 EDT 2025
Tue Jun 17 21:22:45 EDT 2025
Tue Jun 10 20:47:25 EDT 2025
Fri Jun 27 04:40:48 EDT 2025
Thu Apr 03 07:00:04 EDT 2025
Tue Jul 01 03:33:46 EDT 2025
Thu Apr 24 23:08:36 EDT 2025
Thu Jun 26 23:07:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Candida albicans
Biofilm
Caries
Nanochitosan
Streptococcus mutans
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c661t-e710c7949e9263cef0610e22c5e24978eff10b2b17e162a32e2e8e5381bab5063
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2512-2579
0009-0005-2124-5669
0000-0003-2285-2602
0000-0001-7478-8169
0000-0001-7197-2075
0000-0001-9368-8737
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13104-019-4422-x
PMID 31287001
PQID 2254518118
PQPubID 23479
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_81f7698e6fa846968422120f1f2acc39
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6613267
proquest_miscellaneous_2254518118
gale_infotracmisc_A592924371
gale_infotracacademiconefile_A592924371
gale_incontextgauss_IOV_A592924371
pubmed_primary_31287001
crossref_citationtrail_10_1186_s13104_019_4422_x
crossref_primary_10_1186_s13104_019_4422_x
nii_cinii_1870583643265714304
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-07-08
PublicationDateYYYYMMDD 2019-07-08
PublicationDate_xml – month: 07
  year: 2019
  text: 2019-07-08
  day: 08
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC Research Notes
PublicationTitleAlternate BMC Res Notes
PublicationYear 2019
Publisher Springer Science and Business Media LLC
BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: Springer Science and Business Media LLC
– name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References A Aliasghari (4422_CR31) 2016; 8
DH Ngo (4422_CR15) 2014
JC Fernandes (4422_CR19) 2008; 25
ZS Ardestani (4422_CR32) 2016; 2
A Sandra (4422_CR7) 2013; 22
N Beyth (4422_CR8) 2015
S Liu (4422_CR5) 2017; 4
L Guo (4422_CR35) 2015; 5
S Gregoire (4422_CR29) 2011; 77
J Venkatesan (4422_CR12) 2010; 8
W Zhao (4422_CR36) 2014; 6
HL Bernard (4422_CR30) 2017; 98
TP Cenci (4422_CR26) 2008; 53
D Duangporn (4422_CR3) 2017; 67
D Di Stasio (4422_CR6) 2018; 32
D Raafat (4422_CR22) 2009; 2
M Ramasamy (4422_CR11) 2016; 2016
MZ Karagozlu (4422_CR14) 2014
T Kean (4422_CR20) 2010; 62
RY Pelgrift (4422_CR9) 2013; 65
E Costa (4422_CR24) 2014; 3
R Ikono (4422_CR25) 2018; 4
H Sztajer (4422_CR27) 2014; 8
SY Ong (4422_CR21) 2008; 29
M Kong (4422_CR33) 2010; 144
JC Fernandes (4422_CR18) 2009; 109
M Mühling (4422_CR10) 2009; 68
JO Barbosa (4422_CR28) 2016; 11
MN Kumar (4422_CR13) 2004; 104
M Feldman (4422_CR4) 2016; 7
D Kim (4422_CR1) 2017; 7
LE ChávezdePaz (4422_CR23) 2011; 77
ML Falsetta (4422_CR2) 2014; 82
EM Costa (4422_CR17) 2012; 18
P Baldrick (4422_CR16) 2010; 56
T Ikeda (4422_CR34) 1984; 185
References_xml – volume: 32
  start-page: 113
  year: 2018
  ident: 4422_CR6
  publication-title: J Biol Regul Homeost Agents
– volume: 98
  start-page: 105
  year: 2017
  ident: 4422_CR30
  publication-title: Colloids Surf B.
– volume: 67
  start-page: 98
  year: 2017
  ident: 4422_CR3
  publication-title: Int Dent J
  doi: 10.1111/idj.12261
– volume: 62
  start-page: 3
  year: 2010
  ident: 4422_CR20
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2009.09.004
– volume: 53
  start-page: 755
  year: 2008
  ident: 4422_CR26
  publication-title: Arch Oral Biol
  doi: 10.1016/j.archoralbio.2008.02.015
– volume: 8
  start-page: 93
  year: 2016
  ident: 4422_CR31
  publication-title: Iran J Microbiol
– volume: 4
  start-page: 1
  year: 2017
  ident: 4422_CR5
  publication-title: Biomed Res Int
– volume: 82
  start-page: 1968
  year: 2014
  ident: 4422_CR2
  publication-title: Infect Immun
  doi: 10.1128/IAI.00087-14
– volume: 65
  start-page: 1803
  year: 2013
  ident: 4422_CR9
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2013.07.011
– volume: 8
  start-page: 2256
  year: 2014
  ident: 4422_CR27
  publication-title: ISME J
  doi: 10.1038/ismej.2014.73
– volume: 109
  start-page: 854
  year: 2009
  ident: 4422_CR18
  publication-title: Ultramicroscopy
  doi: 10.1016/j.ultramic.2009.03.015
– volume: 3
  start-page: 908
  year: 2014
  ident: 4422_CR24
  publication-title: Pathogens.
  doi: 10.3390/pathogens3040908
– volume: 4
  start-page: 1
  year: 2018
  ident: 4422_CR25
  publication-title: Biomed Phys Eng Express
  doi: 10.1088/2057-1976/aac9f8
– volume: 7
  start-page: 41332
  year: 2017
  ident: 4422_CR1
  publication-title: Sci Rep
  doi: 10.1038/srep41332
– volume: 77
  start-page: 6357
  year: 2011
  ident: 4422_CR29
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.05203-11
– volume: 2
  start-page: 186
  year: 2009
  ident: 4422_CR22
  publication-title: Microb Biotechnol
  doi: 10.1111/j.1751-7915.2008.00080.x
– volume: 18
  start-page: 305
  year: 2012
  ident: 4422_CR17
  publication-title: Anaerobe
  doi: 10.1016/j.anaerobe.2012.04.009
– volume: 2016
  start-page: 1
  year: 2016
  ident: 4422_CR11
  publication-title: Biomed Res Int
  doi: 10.1155/2016/1851242
– volume: 77
  start-page: 3892
  year: 2011
  ident: 4422_CR23
  publication-title: Appl Environ Microbiol.
  doi: 10.1128/AEM.02941-10
– volume: 5
  start-page: 1
  year: 2015
  ident: 4422_CR35
  publication-title: Sci Rep.
– volume: 2
  start-page: 28
  year: 2016
  ident: 4422_CR32
  publication-title: Curr Med Mycol.
– volume: 11
  start-page: e0150457
  year: 2016
  ident: 4422_CR28
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0150457
– year: 2015
  ident: 4422_CR8
  publication-title: Evid Based Complement Alternat Med.
  doi: 10.1155/2015/246012
– volume: 185
  start-page: 869
  year: 1984
  ident: 4422_CR34
  publication-title: Macromol Chem Phys.
  doi: 10.1002/macp.1984.021850503
– volume: 68
  start-page: 278
  year: 2009
  ident: 4422_CR10
  publication-title: Mar Environ Res
  doi: 10.1016/j.marenvres.2009.07.001
– volume: 104
  start-page: 6017
  year: 2004
  ident: 4422_CR13
  publication-title: Chem Rev
  doi: 10.1021/cr030441b
– volume: 7
  start-page: 1
  year: 2016
  ident: 4422_CR4
  publication-title: Front Microbiol.
  doi: 10.3389/fmicb.2016.00140
– volume: 25
  start-page: 922
  year: 2008
  ident: 4422_CR19
  publication-title: Food Microbiol
  doi: 10.1016/j.fm.2008.05.003
– volume: 144
  start-page: 51
  year: 2010
  ident: 4422_CR33
  publication-title: Int J Food Microbiol.
  doi: 10.1016/j.ijfoodmicro.2010.09.012
– start-page: 15
  volume-title: Advances in food and nutrition research
  year: 2014
  ident: 4422_CR15
  doi: 10.1016/b978-0-12-800268-1.00002-0
– volume: 6
  start-page: 3572
  year: 2014
  ident: 4422_CR36
  publication-title: Nutrients
  doi: 10.3390/nu6093572
– volume: 8
  start-page: 2252
  year: 2010
  ident: 4422_CR12
  publication-title: Mar Drugs.
  doi: 10.3390/md8082252
– volume: 22
  start-page: 13
  year: 2013
  ident: 4422_CR7
  publication-title: J Prosthodont.
  doi: 10.1111/j.1532-849X.2012.00906.x
– volume: 29
  start-page: 4323
  year: 2008
  ident: 4422_CR21
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2008.07.034
– start-page: 215
  volume-title: Advances in food and nutrition research
  year: 2014
  ident: 4422_CR14
  doi: 10.1016/B978-0-12-800269-8.00012-9
– volume: 56
  start-page: 290
  year: 2010
  ident: 4422_CR16
  publication-title: Regul Toxicol Pharmacol
  doi: 10.1016/j.yrtph.2009.09.015
SSID ssj0061881
Score 2.4607713
Snippet Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental...
Objective Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental...
Abstract Objective Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
nii
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 383
SubjectTerms Anti-Infective Agents
Anti-Infective Agents - chemistry
Anti-Infective Agents - pharmacology
Biofilm
Biofilms
Biofilms - drug effects
Biofilms - growth & development
Biology (General)
Candida albicans
Candida albicans - drug effects
Candida albicans - physiology
Care and treatment
Caries
Causes of
Child
Children
Chitin
Chitosan
Chitosan - chemistry
Dental Caries
Dental Caries - drug therapy
Dental Caries - microbiology
Dental Plaque
Dental Plaque - drug therapy
Dental Plaque - microbiology
Health aspects
Humans
Medicine
Microbial Viability
Microbial Viability - drug effects
Microorganisms
Microscopy, Electron, Transmission
Nanochitosan
Nanoparticles
Nanoparticles - chemistry
Nanoparticles - ultrastructure
Particle Size
Pathogenic microorganisms
Q1-390
QH301-705.5
R
Research Note
Science (General)
Streptococcus mutans
Streptococcus mutans - drug effects
Streptococcus mutans - physiology
Time Factors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9RAEF60IPgi_ja2lVUEQVia3SSbzWMtliqoL1b6tuxuZmuwlxRzgfa_dybJHY2IvvhyD5cZ7jIzO_stO_MNY6_LyoRQKhDeqFLkoa5FVQYpXJVmMSt0jKOnP33WJ6f5x7Pi7MaoL6oJm-iBJ8MdGBlLXRnQ0eFWWdG1EWbbNMqoXAjZ2LqHe97mMDXlYC2NkfMdpjT6oJeIYqjaohI56ourxS40kvVvU_Lttmn-BDd_r5q8sQ0d32f3ZvzID6f__YDdgvYhuzNNlLx-xH5gtuzoaqDrXcvRas2qGamWUIdaGGhSBHfnrkFUyOlG-nLdYUoMQ89XA-LEHnVqfkS9LrXj7sJTluw5NWwJasrEczX3DY35XvWP2enx-69HJ2KepyAC7sJrAYgmAq6_CiqlswDoBpmCUqEARYPmIEaZeuVlCVIrlylQYAAzovTOF4hlnrCdtmvhGeO1z0DjSaiAUuUYB5WvgRhG0TPa11masHRjXxtmsnGaeXFhx0OH0XZyiUWXWHKJvUrY263K5cS08Tfhd-S0rSCRZI9fYOjYOXTsv0InYa_I5ZZoMFqqszl3Q9_bD1--2cMCYSNxNcqEvZmFYodvENzctoB2IOasheTeQhLXaVg83sfIQmvQp8Q0WZgM4aDSBY2gT_OEvdzEnCVVKn5roRt6iyk3LxCJSZOwp1MMbl8cLW6odCBh5SI6F5ZZPmmb7yONOMYE_nr5_H-YcpfdVenYDidSs8d21j8H2Ee0tvYvxoX5Cz-oOHo
  priority: 102
  providerName: Directory of Open Access Journals
Title Nanochitosan antimicrobial activity against Streptococcus mutans and Candida albicans dual-species biofilms
URI https://cir.nii.ac.jp/crid/1870583643265714304
https://www.ncbi.nlm.nih.gov/pubmed/31287001
https://www.proquest.com/docview/2254518118
https://pubmed.ncbi.nlm.nih.gov/PMC6613267
https://doaj.org/article/81f7698e6fa846968422120f1f2acc39
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZ2EWgviDuBrQoICQkpLHYS23lAqJs2jUobCCjqm2U7Tolok9E00vbvOSdNK4IKL43U2Klybv7c43M-Ql6LVFormAuMZCKIbZYFqbA00GkY5VHC87zV9OUVvxjHo0ky2SFreqtOgPXWrR3ySY0Xs3c3v24_gMO_bx1e8uOaAkbBsxRpEMewtwJIuQ8Lk0BCg8t4k1TgVEraJTa3TjsgdyOKib-OIWa9SrXN_Dche7csim1w9O9TlX8sU-f3yb0OX_rDlUE8IDuufEjurBgnbx-RnxBNK0wdVLUufZBqMS_aVkwwB0sckEnC11NdAGr0MWN9vawgZNqm9ucN4Mga5mT-KdbCZNrXM4NRtPaxoCvAok3Yd_umQBrwef2YjM_Pvp1eBB3fQmBhlV4GDtCGBf9MXcp4ZB2oiYaOMZs4hkR0Ls9paJihwlHOdMQcc9JBxKRGmwSwzhOyV1ale0b8zESOw04pcYLFYCepyRx2IKUs5CaLQo-Ea_kq2zUjR06MmWo3JZKrlXYUaEehdtSNR95uplyvOnH8b_AJKm0zEJtot19Ui6nqfFJJmgueSsdzDSgsxYwkLORhTnOmrY1Sj7xClStsk1HiOZypbupaffz0XQ0TgJXYy5F65E03KK_gDazuyhpADthZqzfysDcS_Nj2bh-BZYE08JOCFSYyArjIeIIU9WHskZdrm1M4FQ_Hla5qagUhOU4AqVHpkacrG9y8-NqgPSJ61tmTTP9OWfxo24yDTcCvi-f_fOYLcsDCtgYuCOUh2VsuGncEEG1pBmRXTMSA7A-Ho68juJ6cXX3-Mmj_8Bi0Tvkbg3Q40Q
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanochitosan+antimicrobial+activity+against+Streptococcus+mutans+and+Candida+albicans+dual-species+biofilms&rft.jtitle=BMC+research+notes&rft.au=Ikono%2C+Radyum&rft.au=Vibriani%2C+Agnia&rft.au=Wibowo%2C+Indra&rft.au=Saputro%2C+Kurniawan+Eko&rft.date=2019-07-08&rft.eissn=1756-0500&rft.volume=12&rft.issue=1&rft.spage=383&rft_id=info:doi/10.1186%2Fs13104-019-4422-x&rft_id=info%3Apmid%2F31287001&rft.externalDocID=31287001
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-0500&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-0500&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-0500&client=summon